Archive for the 'Diabetes Drug' Category

Living Cell Technologies Clinical Trial Proves Positive For All The Type 1 Diabetes Patients

Thursday, July 24th, 2008

Living Cell Technologies Limited has today released the results of their DiabeCell(R) trials on Six patients with insulin dependent (type 1) diabetes. The company has released the results describing clinical benefit of the Company’s encapsulated porcine islet cells for the treatment of type 1 diabetes.

FA Device Could be Used to Detect Diabetes Before Its Diagnosis

Thursday, July 24th, 2008

According to the scientists of the University of Michigan, they have created a new instrument called as FA device which is capable of detecting the metabolic stress and tissue damage that occurs long before the first symptoms of the diabetes.

Glumetza (Type 2 Diabetic Drug) Would be Promoted In The U.S Market by Santarus

Thursday, July 24th, 2008

According to the announcement done on 22 of July 2008, by Santarus Inc.(a renowned San Deigo based company), they have signed an agreement with Depomed Inc. to promote Glumetza (a diabetic drug ) in the U.S market.

Kronos Optimal Health Programme Could Stop Diabetes Before It Starts

Saturday, July 12th, 2008

The new course created by the Kronos Optimal Health Company may help the prediabetic patients to avoid Diabetes.

US Researchers Found Rosiglitazone To Prevent Diabetic Retinopathy

Tuesday, July 8th, 2008

A team of researchers at the Jules Stein Eye Institute and other of their counterparts in the USA, have found that the rosiglitazone (Avandia) treated diabetes patients are less likely to develop proliferative diabetic retinopathy. The researchers have tested the records of nearly 124 patients treated with rosiglitazone and compared them with records of 158 [...]

FDA To Go For More Test For Diabetes Drug To Avoid Heart Problems

Thursday, July 3rd, 2008

At the two day meeting on the standard of diabetes drug, the FDA officials have decided that the testing standard on the type 2 diabetes drug should more thorough to avoid the risk of heart problems. The panel of outside experts voted 14-to-2, at the end of a two-day meeting, to recommend that all makers [...]

FDA To Discuss The Diabetes Drug Standard In Two Day Meeting

Wednesday, July 2nd, 2008

A prominent medical expert, Cardiologist Steven Nissen of the Cleveland Clinic urged the U.S. Food and Drug Administration to raise its standards for approving diabetes drugs on Tuesday. Nissen said that companies need to prove new drugs don’t increase cardiovascular disease, the leading killer of diabetics. Nissen suggested that, in addition to requiring more [...]

Molecular Malfunction May Lead To Diabetes

Wednesday, July 2nd, 2008

Researchers in the the department of bioengineering at the University of California, San Diego have discovered that molecular malfunction may be the reason behind the development of high blood pressure, diabetes and immune problems. Rogue versions of enzymes known as proteases roam the body, clipping off working segments of the receptors that allow [...]

FDA To Reconsider The Diabetes Drug Standard For Safety And Effectiveness

Wednesday, July 2nd, 2008

The Food And Drug Administration officials are likely to have a meeting to discuss the proper regulations for the diabetes medicines. They are likely to make the rules and regulations tougher. They reconsider the Government regulations after they were criticized last year for their handling of heart risks connected with a widely used GlaxoSmithKline [...]

Diabetes Linked To Faster Mental Decline (Dementia) in Adults

Monday, June 30th, 2008

The recent study by the team of researchers at the Harvard Medical School in Boston, have found relation between diabetes and dementia. The study has established that the older people with type 2 diabetes are more likely to suffer from mental decline as they age. So far many studies have shown the relation between [...]